Reperfusion After Fibrinolytic Therapy (RAFT): An open-label, multi-centre, randomised controlled trial of bivalirudin versus heparin in rescue percutaneous coronary intervention.
Amir FaourNicholas CollinsTrent WilliamsArshad KhanCraig P JuergensSidney LoDarren L WaltersDerek P ChewJohn K FrenchPublished in: PloS one (2021)
Whether bivalirudin compared with heparin ± GPI reduces bleeding in rescue PCI could not be determined. Slow recruitment and futility in the context of lower-than-expected bleeding event rates led to the termination of this trial (ANZCTR.org.au, ACTRN12610000152022).
Keyphrases
- percutaneous coronary intervention
- acute myocardial infarction
- atrial fibrillation
- st segment elevation myocardial infarction
- study protocol
- st elevation myocardial infarction
- antiplatelet therapy
- acute coronary syndrome
- coronary artery disease
- venous thromboembolism
- coronary artery bypass grafting
- growth factor
- randomized controlled trial
- clinical trial
- coronary artery bypass
- phase iii
- sensitive detection
- heart failure
- reduced graphene oxide
- mesenchymal stem cells
- gold nanoparticles
- left ventricular
- subarachnoid hemorrhage